Amicus Therapeutics

FOLD

FOLD
Amicus Therapeutics Stock Quote
$9.76 -$0.35 -3.5%
BATS BZX Real Time Price as of December 9, 2019, 4:00 p.m. EST View Interactive FOLD Charts

A clinical-stage biopharmaceutical company, which focused on the discovery, development and commercialization of novel small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases.

News & Analysis: Amicus Therapeutics

The Fool has written over 100 articles on Amicus Therapeutics.

All

Market Moves

Earnings


Is Amicus Therapeutics a Buy?

The gene therapy stock is trading at its lowest level in over two years. It recently announced preliminary third-quarter 2019 operating results.










Interactive Chart